Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

LOC100041019 Inhibitors

The chemical class designated as LOC100041019 Inhibitors encompasses a range of compounds specifically formulated to target and inhibit the activity of the gene product expressed by LOC100041019. This gene, discovered through extensive genomic and molecular research, has been recognized for its involvement in a variety of cellular functions and processes. The functionality of LOC100041019 is notably context-sensitive, with its role in cellular mechanisms varying according to the cellular environment and external stimuli. Inhibitors targeting LOC100041019 are meticulously developed to selectively bind to the proteins or enzymes that are produced as a result of the gene's expression. This selective binding is integral to the mechanism of these inhibitors, as it directly influences the biochemical pathways involving the LOC100041019 gene product. By modulating the activity of this gene product, the inhibitors aim to alter the associated cellular processes, thereby impacting specific cellular functions and mechanisms.

The development of LOC100041019 Inhibitors is a complex and interdisciplinary undertaking, requiring a deep integration of knowledge from molecular biology, chemistry, and structural biology. The initial step in this process involves attaining a comprehensive understanding of the structure and function of the LOC100041019 gene product. Techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational molecular modeling are utilized to gain a detailed perspective of the target molecule. This in-depth knowledge enables the rational design of inhibitors that are effective in their interaction with the target and exhibit a high degree of specificity. Typically, these inhibitors are small molecules, designed for efficient cellular penetration and to establish a stable and potent interaction with their target. The molecular design of these inhibitors is carefully optimized to ensure robust interactions with the target molecule, usually involving the formation of hydrogen bonds, hydrophobic interactions, and van der Waals forces. The efficacy of these inhibitors is rigorously tested through various biochemical assays in vitro. These assays are critical for assessing the inhibitors' potency, specificity, and overall interaction dynamics, providing key insights into their behavior in controlled experimental conditions. Such research is essential for advancing our understanding of the inhibitors' mechanism of action and their potential impact on the complex network of cellular pathways influenced by LOC100041019.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Binds to DNA and prevents the transcription elongation by RNA polymerase, which could nonspecifically inhibit gene expression.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

Selectively inhibits RNA polymerase II, potentially reducing mRNA synthesis and subsequent protein expression.

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$97.00
$328.00
$676.00
$1467.00
6
(1)

Binds to bacterial RNA polymerase, inhibiting transcription initiation; its effect on eukaryotic cells could be indirect and off-target.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

A diterpene triepoxide that can inhibit transcription by RNA polymerase II, thereby reducing gene expression.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$66.00
$101.00
$143.00
85
(5)

Alkylates DNA and forms crosslinks, potentially blocking DNA replication and transcription.

Cordycepin

73-03-0sc-203902
10 mg
$101.00
5
(1)

Inhibits RNA synthesis by terminating mRNA elongation prematurely when it is incorporated into RNA.

Chromomycin A3

7059-24-7sc-200907
10 mg
$260.00
(1)

Binds to GC-rich regions of DNA, inhibiting RNA synthesis by preventing the binding of transcription factors.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Binds to DNA and inhibits RNA synthesis by preventing the binding of transcription factors to GC-rich sequences.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$58.00
$186.00
$94.00
21
(2)

Inhibits DNA topoisomerase I, leading to DNA damage and potentially affecting transcription processes.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

Inhibits casein kinase II activity, which can affect the phosphorylation state of transcription factors and RNA polymerase II, possibly modulating gene expression.